|
Cytori Therapeutics, Inc. Announces Closing of Financing
MarketWatch The preferred stock is convertible into shares of Cytori’s common stock at the option of the investors at a conversion price of $0.52. Cytori also issued warrants to purchase an aggregate of 25,961,541 shares of Cytori’s common stock at an exercise … |
